News articles about Acadia Healthcare Company (NASDAQ:ACHC) have been trending somewhat positive on Friday, according to Alpha One. The research firm, a subsidiary of Accern, scores the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Alpha One ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Acadia Healthcare Company earned a media sentiment score of 0.06 on Alpha One’s scale. Alpha One also assigned media coverage about the company an impact score of 43 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the headlines that may have effected Alpha One’s analysis:

Insider Buying and Selling by Quarter for Acadia Healthcare Company (NASDAQ:ACHC)

Acadia Healthcare Company (NASDAQ ACHC) traded down 1.61% during mid-day trading on Friday, hitting $45.26. 1,512,129 shares of the stock traded hands. Acadia Healthcare Company has a 12 month low of $32.54 and a 12 month high of $62.48. The company has a market cap of $3.97 billion, a price-to-earnings ratio of 263.14 and a beta of 1.11. The stock’s 50 day moving average is $43.91 and its 200-day moving average is $40.93.

Acadia Healthcare Company (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, April 25th. The company reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The business had revenue of $679.20 million for the quarter, compared to the consensus estimate of $691.74 million. Acadia Healthcare Company had a net margin of 0.53% and a return on equity of 8.89%. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.55 earnings per share. On average, equities research analysts anticipate that Acadia Healthcare Company will post $2.45 EPS for the current year.

A number of research analysts have weighed in on ACHC shares. Zacks Investment Research raised shares of Acadia Healthcare Company from a “sell” rating to a “hold” rating in a research note on Thursday, February 16th. Mizuho reissued a “buy” rating and issued a $52.00 target price (up from $45.00) on shares of Acadia Healthcare Company in a research note on Monday, February 27th. Cantor Fitzgerald reissued a “neutral” rating and issued a $45.00 target price on shares of Acadia Healthcare Company in a research note on Monday, February 27th. Citigroup Inc. raised their target price on shares of Acadia Healthcare Company from $43.00 to $52.00 and gave the stock a “buy” rating in a research note on Monday, March 6th. Finally, TheStreet raised shares of Acadia Healthcare Company from a “d+” rating to a “c-” rating in a research note on Friday, March 3rd. Five equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $57.82.

COPYRIGHT VIOLATION NOTICE: “Acadia Healthcare Company (ACHC) Receiving Somewhat Positive Media Coverage, Analysis Finds” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/06/17/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-acadia-healthcare-company-achc-share-price-updated-updated-updated.html.

In other Acadia Healthcare Company news, Director Reeve B. Waud sold 724,694 shares of the stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $45.53, for a total transaction of $32,995,317.82. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP Randall P. Goldberg sold 4,925 shares of the stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $45.18, for a total transaction of $222,511.50. Following the transaction, the vice president now directly owns 10,607 shares in the company, valued at approximately $479,224.26. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 866,102 shares of company stock worth $39,314,769. 11.10% of the stock is currently owned by insiders.

About Acadia Healthcare Company

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.